Hilar Cholangiocarcinoma — Trials

Hilar Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

62 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06420349	NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma	terminated	Phase 1	7	Mayo ClinicOTHER	1	Dec 22, 2025	clinicaltrials
NCT00630890	Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)	terminated	Phase 1	11	University of California, San FranciscoOTHER	1	Sep 11, 2015	clinicaltrials